IM Cannabis (IMCC) Gross Profit (QoQ) (2020 - 2026)
IM Cannabis (IMCC) Gross Profit (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.74 Bn | 86.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.87 Bn | 32.13 Bn | 1.97 Bn |
| 3 | Zoetis | 32.28 Bn | 30.34 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.51 Bn | 23.45 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.14 Bn | 20.98 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - |
| 7 | Viatris | 20.25 Bn | 18.44 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.89 Bn | 16.57 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn |
| 10 | IM Cannabis | 510,233.61 | -221,888.90 | 1.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,659.73% |
| Dec 31, 2025 | -97.04% |
| Sep 30, 2025 | -19.72% |
| Jun 30, 2025 | 2.87% |
| Mar 31, 2025 | 25.25% |
| Dec 31, 2024 | -16.86% |
| Sep 30, 2024 | 273.96% |
| Jun 30, 2024 | -53.26% |
| Mar 31, 2024 | 113.72% |
| Dec 31, 2023 | -68.69% |
| Sep 30, 2023 | -23.31% |
| Jun 30, 2023 | 19.77% |
| Mar 31, 2023 | 12.02% |
| Dec 31, 2022 | 28.06% |
| Sep 30, 2022 | -13.26% |
| Jun 30, 2022 | -9.08% |
| Mar 31, 2022 | 144.46% |
| Dec 31, 2021 | 1,403.57% |
| Sep 30, 2021 | 87.11% |
| Jun 30, 2021 | -111.63% |